Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
January 30-31, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Radisson Hotel Narita | Tokyo, Japan
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
May 15-16, 2019

21st World Congress on Advances in Gastroenterology and Hepatology

Mercure Melbourne Albert Park, Melbourne, Australia
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Clinical Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in